Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dose Schedule Study”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT01277484
What this trial is testing

Dose Finding Study of Post-BMT Decitabine Maintenance Treatment in Higher-risk MDS and MDS/AML

Who this might be right for
Myelodysplastic SyndromeAcute Myeloid Leukemia
Seoul St. Mary's Hospital 19
Early research (Phase 1)Study completedNCT00537147
What this trial is testing

Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4delta30) in Healthy Adults

Who this might be right for
West Nile Fever
National Institute of Allergy and Infectious Diseases (NIAID) 26
Early research (Phase 1)Study completedNCT02666287
What this trial is testing

GSK961081 Alone and With Fluticasone Furoate (FF), Phase 1 (Ph1), Single Dose Regimen (SD), Repeat Dose Regimen (RD), Pharmacokinetic (PK) Study in Healthy Volunteer (HV)

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 48
Testing effectiveness (Phase 2)Study completedNCT00004248
What this trial is testing

Doxorubicin and Interleukin-2 in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Who this might be right for
Liver Cancer
Roswell Park Cancer Institute 24
Early research (Phase 1)Study completedNCT00441155
What this trial is testing

Patients Completing Core Protocol (CAMN107A2103), Exhibiting Stable Disease (SD), Partial Response (PR) or Complete Response (CR) to Nilotinib in Combination With Imatinib

Who this might be right for
Gastrointestinal Stromal Tumors
Novartis Pharmaceuticals 14
Early research (Phase 1)Active Not RecruitingNCT04091126
What this trial is testing

Study of Belantamab Mafodotin Plus Standard of Care (SoC) in Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
GlaxoSmithKline 118
Large-scale testing (Phase 3)Study completedNCT01229397
What this trial is testing

Immunogenicity and Safety of a Single 0.5 mL Dose of Inflexal V With a 0.25 mL 2-dose Regimen of Inflexal V

Who this might be right for
Influenza
Crucell Holland BV 205
Post-approval studies (Phase 4)Study completedNCT00337558
What this trial is testing

Solifenacin With Bladder Training Versus Solifenacin Alone in Patients With Overactive Bladder (SOLAR)

Who this might be right for
Overactive BladderUrinary IncontinenceUrge Incontinence
Astellas Pharma Inc 643
Testing effectiveness (Phase 2)Looking for participantsNCT06988488
What this trial is testing

Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 62
Early research (Phase 1)Study completedNCT04758962
What this trial is testing

The Safety of and Immune Response to Varying Doses of a Vaccine Against COVID-19 in Healthy Adults

Who this might be right for
Virus Diseases
GlaxoSmithKline 10
Not applicableEnded earlyNCT01100346
What this trial is testing

Predictive Factors of Ovarian Response in Ovulation Induction With Intrauterine Insemination of a Gonal-f Low-dose Regimen

Who this might be right for
Infertility
Merck KGaA, Darmstadt, Germany 30
Testing effectiveness (Phase 2)Ended earlyNCT06082843
What this trial is testing

Test Whether Avenciguat Helps People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver) Who Had Bleeding in the Esophagus or Fluid Accumulation in the Belly

Who this might be right for
Hypertension, PortalLiver Cirrhosis
Boehringer Ingelheim 22
Large-scale testing (Phase 3)UnknownNCT05216484
What this trial is testing

Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) in Adults Aged 18 Years and Above (6 Months After Two Doses)

Who this might be right for
SARS-CoV-2 Infection
Chinese Academy of Medical Sciences 480
Early research (Phase 1)Study completedNCT04203433
What this trial is testing

DLX105-DMP in Subjects With Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
DelArrivo, Inc. 10
Large-scale testing (Phase 3)Study completedNCT00287092
What this trial is testing

Comparison of Safety and Immunogenicity of Pediacel™ and Infanrix™ IPV+Hib (Penta) Given in a 3 Dose Schedule in Infants

Who this might be right for
PertussisDiphtheriaTetanus+2 more
Sanofi Pasteur, a Sanofi Company 807
Large-scale testing (Phase 3)Study completedNCT00141219
What this trial is testing

Pregabalin Peripheral Neuropathic Pain Study

Who this might be right for
Diabetic NeuropathiesNeuralgia
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 241
Large-scale testing (Phase 3)Study completedNCT03135834
What this trial is testing

A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to <26 Years of Age.

Who this might be right for
Meningococcal Vaccine
Pfizer 1,610
Testing effectiveness (Phase 2)Study completedNCT01767311
What this trial is testing

Evaluate Safety, Tolerability, and Efficacy of Lecanemab in Subjects With Early Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Eisai Inc. 856
Testing effectiveness (Phase 2)Study completedNCT00107237
What this trial is testing

AEE788 and Everolimus in Treating Patients With Recurrent or Relapsed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Novartis Pharmaceuticals 16
Testing effectiveness (Phase 2)Study completedNCT00268593
What this trial is testing

Pilot Efficacy Study of PI-88 With Docetaxel to Treat Prostate Cancer

Who this might be right for
Prostate Cancer
Progen Pharmaceuticals 48
Next Page